Literature DB >> 23413979

Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.

Hermann C Altmeppen1, Johannes Prox, Berta Puig, Frank Dohler, Clemens Falker, Susanne Krasemann, Markus Glatzel.   

Abstract

The cellular prion protein (PrP(C)) plays important roles in neurodegenerative diseases. First, it is the well-established substrate for the conformational conversion into its pathogenic isoform (PrP(Sc)) giving rise to progressive and fatal prion diseases. Moreover, several recent reports highlight important roles of PrP(C) in other neurodegenerative conditions such as Alzheimer's disease. Since PrP(C) is subject to proteolytic processing, here we discuss the two main cleavage events under physiological conditions, α-cleavage and shedding. We focus on how these cleavages and the resulting fragments may impact prion diseases as well as other neurodegenerative proteinopathies. Finally, we discuss the recently identified sheddase of PrP(C), namely the metalloprotease ADAM10, with regard to therapeutic potential against neurodegenerative diseases.
© 2013 The Authors Journal compilation © 2013 FEBS.

Entities:  

Keywords:  ADAM10; Alzheimer's disease; neurodegeneration; neurotoxic oligomers; prion disease; prion protein; shedding; α-cleavage; β-amyloid

Mesh:

Substances:

Year:  2013        PMID: 23413979     DOI: 10.1111/febs.12196

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  19 in total

1.  Shedding light on prion disease.

Authors:  Markus Glatzel; Luise Linsenmeier; Frank Dohler; Susanne Krasemann; Berta Puig; Hermann C Altmeppen
Journal:  Prion       Date:  2015       Impact factor: 3.931

2.  Application of high-throughput, capillary-based Western analysis to modulated cleavage of the cellular prion protein.

Authors:  Andrew R Castle; Nathalie Daude; Sabine Gilch; David Westaway
Journal:  J Biol Chem       Date:  2018-12-21       Impact factor: 5.157

Review 3.  Taking advantage of physiological proteolytic processing of the prion protein for a therapeutic perspective in prion and Alzheimer diseases.

Authors:  Maxime Béland; Xavier Roucou
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

Review 4.  Microglia, Lifestyle Stress, and Neurodegeneration.

Authors:  Charlotte Madore; Zhuoran Yin; Jeffrey Leibowitz; Oleg Butovsky
Journal:  Immunity       Date:  2020-01-07       Impact factor: 31.745

5.  The sheddase ADAM10 is a potent modulator of prion disease.

Authors:  Hermann C Altmeppen; Johannes Prox; Susanne Krasemann; Berta Puig; Katharina Kruszewski; Frank Dohler; Christian Bernreuther; Ana Hoxha; Luise Linsenmeier; Beata Sikorska; Pawel P Liberski; Udo Bartsch; Paul Saftig; Markus Glatzel
Journal:  Elife       Date:  2015-02-05       Impact factor: 8.140

Review 6.  Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein.

Authors:  Behnam Mohammadi; Feizhi Song; Andreu Matamoros-Angles; Mohsin Shafiq; Markus Damme; Berta Puig; Markus Glatzel; Hermann Clemens Altmeppen
Journal:  Cell Tissue Res       Date:  2022-01-27       Impact factor: 5.249

Review 7.  Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity.

Authors:  Stefanie A G Black; Peter K Stys; Gerald W Zamponi; Shigeki Tsutsui
Journal:  Front Cell Dev Biol       Date:  2014-08-28

8.  The Pathogenic A116V Mutation Enhances Ion-Selective Channel Formation by Prion Protein in Membranes.

Authors:  Ambadi Thody Sabareesan; Jogender Singh; Samrat Roy; Jayant B Udgaonkar; M K Mathew
Journal:  Biophys J       Date:  2016-04-26       Impact factor: 4.033

Review 9.  Nanoparticle-Based and Bioengineered Probes and Sensors to Detect Physiological and Pathological Biomarkers in Neural Cells.

Authors:  Dusica Maysinger; Jeff Ji; Eliza Hutter; Elis Cooper
Journal:  Front Neurosci       Date:  2015-12-18       Impact factor: 4.677

10.  Prion fragment peptides are digested with membrane type matrix metalloproteinases and acquire enzyme resistance through Cu²⁺-binding.

Authors:  Aya Kojima; Motomi Konishi; Toshifumi Akizawa
Journal:  Biomolecules       Date:  2014-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.